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The association of an IS440-sul3 platform with Tn21 class 1 integrons carried by IncI1 plasmids encoding
extended-spectrum -lactamases (ESBLs; mainly SHV-12 and CTX-M-14) among worldwide Escherichia coli
clones of phylogroups A (ST10, ST23, and ST46), B1 (ST155, ST351, and ST359), and D/B2 (ST131) is
reported. An in silico comparative analysis of sul3 elements available in the GenBank database shows the
evolution of sul3 platforms by hosting different transposable elements facilitating the potential genesis of IS26
composite transposons and further insertion element-mediated promoted arrangements.
Acquired resistance to sulfonamides is due to the presence
of dihydropteroate synthase (DHPS) genes located on class 1
integrons (sul1 and sul3) or genetic islands bearing Tn5393 and
ISCR2 (sul2) (14, 23, 25). Since its first description in the early
1960s, there is evidence of the spread of plasmids containing
sul1 and sul2 among different hosts (10, 12, 13, 19, 26). The sul3
integrons have been increasingly reported among animals and,
to a lesser extent, among humans since they were identified in
the mid-1990s (2, 4, 11, 23, 24, 32). However, the genetic
elements linked to their spread remain scarcely explored (2,
23, 32).
We analyzed 344 clonally unrelated Enterobacteriaceae iso-
lates (249 Escherichia coli, 56 Klebsiella pneumoniae, 20 En-
terobacter cloacae, 3 Enterobacter aerogenes, 7 Klebsiella oxy-
toca, 6 Salmonella enterica serovar Paratyphi, and 3 Citrobacter
isolates). They included 244 extended-spectrum--lactamase
(ESBL) or metallo--lactamase (MBL) producers obtained
from hospitalized and healthy humans (1988 to 2006) and 100
non-ESBL producers (66 obtained from blood samples from
inpatients and 34 obtained from feces samples from healthy
volunteers without recent exposure to antibiotics or hospital
environments; 1988 to 2006) (see Table 2). Species identifica-
tion and susceptibility testing were performed by using the
automated WIDER system (Fco. Soria Melguizo, Madrid,
Spain) and standard methods (7). Clonal relatedness among
Escherichia coli isolates was established by pulsed-field gel
electrophoresis (PFGE), multilocus sequence typing (MLST)
(30; http://www.mlst.net), and determination of phylogenetic
groups by a multiplex PCR assay (6).
The sul3 gene was detected in 6% of the strains (22 strains
from 12 hospitalized patients, 8 outpatients, and 2 healthy
humans; 1997 to 2006). All were ESBL/MBL-producing E. coli
strains showing different PFGE patterns and sequence types
(ST) linked to phylogroups A (n  9; ST10, ST23, ST46,
ST156, and ST695), B1 (n  6; ST155, ST351, and ST359), and
D/B2, (n  7; ST131, ST350, ST624, and ST648). The most
common ESBLs/MBLs were SHV-12 (n  13) and CTX-M-14
(n  8), followed by CTX-M-15 (n  2), CTX-M-1, CTX-M-9,
VIM-1, and TEM-24 (n  1 each) (see Table 2). Four strains
produced two ESBL/MBL enzymes (CTX-M-14, CTX-M-15,
or VIM-1 plus SHV-12). The sul3 strains often carried other
sul genes (sul1, sul2, and sul3, n  16/22; sul1 and sul3, n  2;
sul2 and sul3, n  1; sul3 only, n  3) and expressed resistance
to sulfonamides (86%), streptomycin (86%), trimethoprim
(77%), tetracycline (77%), and chloramphenicol (64%). The
low prevalence of the sul3 gene is similar to that reported by
other studies (2, 4, 15), in contrast to that reported for the sul1
or sul2 gene (14, 19, 26). The association of sul3 with ESBL E.
coli producers with zoonotic potential (phylogroup B2 E. coli
O25:H4-ST131 and phylogroup D E. coli O25a-ST648, -ST69,
and -ST393) (8, 31) highlights the role of these frequent clones
in the evolution of antibiotic resistance to sulfonamides and
beta-lactams in areas of common exposure to these antibiotics,
such as farms or hospitals.
Characterization of sul3 class 1 integrons and linkage to
Tn21 derivatives were accomplished by analyzing the presence
of intI1, sul3, qacI, tnpM21, and mer21 by PCR/hybridization
and further PCR mapping (Fig. 1 and Table 1). The diversity
of sul3 platforms was established by comparison of restriction
fragment length polymorphism (RFLP) patterns of HindIII-,
EcoRI-, or PstI-digested amplicons, primer walking sequenc-
ing of representatives types, and further analysis of all sul3
elements available in the GenBank database. We detected four
sul3 integron arrangements arbitrarily designated types IS3 to
* Corresponding author. Mailing address: Servicio de Microbi-
ología, Hospital Universitario Ramo´n y Cajal, Carretera de Colmenar,
km 9.1., 28034 Madrid, Spain. Phone: 34-913368330. Fax: 34-
913368809. E-mail: mcoque.hrc@salud.madrid.org.
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IVS3 (Table 2; Fig. 1). The predominant one was type IIIS3,
intI1-estX-psp-aadA2-cmlA1-aadA1-qacI-IS440-sul3, present in
15 ESBL/MBL E. coli strains in our collection since 1997 and
also globally distributed among Enterobacteriaceae of different
origins (2, 3, 16, 17, 28). Two integrons similar to type IIIS3
were intI1-estX-psp-qacI-IS440-sul3 (type IS3) and intI1-estX-
psp-aadA2/aadA1a-qacI-IS440-sul3 (from farm animals in
Switzerland; GenBank accession no. FM242710) (Fig. 2). Dif-
ferences in attC carried by the psp and aadA2 gene cassettes of
different integrons suggest arrangements. Type IIS3, intI1-
dfrA12-gcuF-aadA2-cmlA1-aadA1-qacI-IS440-sul3, has also
been detected in humans, animals, and foods in Europe and
Asia since 2003. Finally, a few sul3 platforms lacking qacI
included intI1-estX-psp-aadA2-cmlA1-aadA1-IS440-sul3 (type
FIG. 1. Schematic representation of sul3 genetic elements characterized by PCR mapping based on the Tn402 and Tn21 sequences. (Top) The
locations of the primers used for the PCR mapping assay are represented with black arrowheads. P13 and P14 hybridize in the qacI gene. (Middle)
The attC sites or 59-base elements were represented by circles patterned as corresponding gene cassettes. (Bottom) Preliminary screening of sul3
elements related to Tn402 and Tn21 was performed as shown in the table. , amplicon of larger size; (), variable amplification results, with
the number of positive results indicated; a, mefB was complete in only two isolates, and in most cases, the gene was truncated at different points
by IS26 (GenBank accession no. HQ875016, HQ875014, and HQ875015); b, this isolate harbors an integron with insertions b and c; c, integron
amplification was reached using primers P9 and P5. tnp21 was found upstream of the integrases of different sul3 integron types (n  10), and a
copy of IS26 was detected downstream of the sul3 gene (n  8). Coexistence of both of the boundaries was detected for 7 isolates. The presence
of the mer operon of Tn21 was inferred by merA.
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IVS3; GenBank accession no. HQ875017), intI1-dfrA12-gcuF-
aadA2-cmlA1-aadA1-IS440-sul3 (27), and partial sequences
aadA1-IS440-sul3-orf1-mefB and aadA3-IS440-sul3-orf1-mefB
(GenBank accession no. FJ196384 and FJ196388, respec-
tively). The sul3 integrons obtained from E. coli and Salmo-
nella enterica isolates from humans and farm animals were
associated with Tn21 platforms often interrupted by IS26 at
different positions (Fig. 1 and 2). Analysis of sequences re-
vealed that a genetic platform, IS440-sul3-orf1-mefB, is specif-
ically located beyond the attC sites of the qacI, aadA1, and
aadA3 gene cassettes of integrons (Fig. 2). The lack of identi-
fiable boundaries for IS440, a putative IS256 family member,
reflects either a single insertion downstream of the last gene
cassette (most probably qacI) of an ancestral integron, fol-
lowed by further excisions and insertions of different gene
cassettes or independent insertions at the end of different attC
sites. The existence of identical integron arrangements lacking
and containing IS26 and IS10 surrounded by direct repeats of
the original target sequence indicates that the IS440-sul3 plat-
form, once acquired, has been the target of further lateral
transfer events. Moreover, complete or partial copies of IS26
at the boundaries of different integrons led to the genesis of
putative IS26 composite transposons (Fig. 1 and 2). The lack of
target site duplication at the sides of these IS26 copies might
indicate the transference of either IS26 composite elements by
homologous recombination among diverse plasmids or larger
platforms in which they were located.
Plasmids carrying sul3 belonged to a diversity of IncI1, IncY,
and IncB/O groups (55 to 220 kb), mostly conjugative ones
(86%). They were identified by PCR typing methods targeting
replication and conjugation sequences of plasmids of Entero-
bacteriaceae (1, 5) and further hybridization of S1 nuclease-
TABLE 1. Oligonucleotides used in this studyb
Primer
no. Primer Sequence (5–3)
GenBank
accession no. Nucleotide positions Source/reference(s)
1 sul1F CGGCGTGGGCTACCTGAACG EU622038 3508–3528 15
2 sul1R GCCGATCGCGTGAAGTTCCG EU622038 3921–3940 15
3 sul2F GCGCTCAAGGCAGATGGCATT M36657 534–555 15
4 sul2R GCGTTTGATACCGGCACCCGT M36657 819–798 15
5 sul3F GAGCAAGATTTTTGGAATCGT AJ459418 2980–3001 23
6 sul3R CTAACCTAGGGCTTTGGATA AJ459418 3770–3750 This study
7 sul3F2 TATCCAAAGCCCTAGGTTAG AJ459418 3750–3770 This study
8 sul3R2 GAACTACGACTGGTTTC AJ459418 2797–2780 This study
9 IntI1F GGGTCAAGGATCTGGATTTCG AF071413 4775–4755 21
10 IntI1R ACATGCGTGTAAATCATCGTCG AF071413 4333–4312 21
11 5CS GGCATCCAAGCAGCAAG AF174129 1236–1252 21
12 3CS AAGCAGACTTGACCTGAT AF174129 2813–2830 21
13 qacIF ACTGGCTCTTTCTGGCTATT EF051039 5064–5084 This study
14 qacIR TAACGATAAGTCCCATGCCA EF051039 5343–5323 This study
15 cmlA1F CACTTCCAAGAACGCAGACA EF051039 2621–2641 This study
16 cmlA1R TTCCGATGCTTCCTAGCAGT U12338 8020–8000 This study
17 cmlA1FR ACTGCTAGGAAGCATCGGAA EF051039 3823–3803 This study
18 aadA2R TGACTTGATGATCTCGCC AF174129 2692–2709 21
19 estX TTCCTTATGTGCATGGGTT EF051039 794–813 This study
20 dfrA12F TTACGTCCAACGTTAGCAC EF051037 1088–1107 This study
21 aadA1R ATTGCGCTGCCATTCTCCA EF051037 4179–4160 This study
22 psp R ATCAGGGTGCCAGACAAGA EF051039 1189–1170 This study
23 IS26F AGCGGTAAATCGTGGAGTGA AF205943 324–344 21
24 IS26R AGGCCGGCATTTTCAGCGTG AF205943 979–960 21
25 IS440R TGCGGGTACTTACTCCTTG FJ587511 6415–6396 This study
26 Orf1R GCAATCCATTAGATTCATAC FJ196385 10347–10327 This study
27 TnpM Fw CCGTGGTGGTGCATAGCAT AF071413 4020–4002 21
28 merA1 ACCATCGGCGGCACCTGCGT AF071413 17597–17578 21
29 merA5 ACCATCGTCAGGTAGGGGAACAA AF071413 16360–16382 21
30 copAF ATGCGCCATAAGGCATTCA NC_0050144 215–234 30
31 repAR AGTCGCTTCAGATGGTCAT NC_005014 1427–1408 30
32 mobP12F GCAAAAGATGACACTGAYCCYGTTTT NC_005014 67717–67743 1, 30
33 mobP12R AGCGATGTGGATGTGAAGGTTATCHGTRTC NC_002122 31165–31120 1, 30
34 ardAF ATGTCTGTTGTTGCACCTGC AP005147 61469–61811 PubMLSTa
35 ardAR TCACCGACGGAACACATGACC AP005147 61926–61906 PubMLST
36 trbAF GCGGTTATCGGGCTACTA AP005147 74976–74959 This study
37 pndAF GAATTCGTTGTCTGTAGCA AP005147 73503–73521 This study
38 sogSF TTCCGGGGCGTAGACAATACT AP005147 93088–93108 PubMLST
39 sogSR AACAGTGATATGCCGTCGC AP005147 93378–93360 PubMLST
40 pilVF CCATATGACCATCCAGTGCG AP005147 114765–114784 PubMLST
41 pilVR AACCACTATCTCGCCAGCAG AP005147 115080–115061 PubMLST
a http://pubmlst.org/perl/bigsdb/bigsdb.pl?dbpubmlst_plasmid_seqdef.
b The primer sequences used in primer walking assays are available upon request.
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F
IG
.
2.
D
iversity
ofthe
sul3
integrons
based
on
published
studies
and
sequences
deposited
in
the
G
enB
ank
database.In
silico
com
parative
analysis
w
as
m
ade
using
B
L
A
ST
and
C
L
U
ST
A
L
softw
ares
available
at
the
B
L
A
ST
(http://w
w
w
.ncbi.nlm
.nih.gov/blast//)
and
C
lustalW
2
(http://w
w
w
.ebi.ac.uk/T
ools/clustalw
2/index.htm
l)
w
ebsites.
T
he
sul3
gene
is
associated
w
ith
class
1
integrons
thatdiffer
from
class
1
sul1
integrons
in
the
3region,w
hich
com
prise
the
gene
cassette
initially
annotated
qacH
butcalled
qacI
afterw
ard
in
order
to
distinguish
itfrom
the
unrelated
qacH
gene
of
Staphylococcus
aureus
(G
enB
ank
accession
no.A
F
205943)
(20,22).
a,the
first
described
sul3
platform
recovered
from
an
E
.colisw
ine
isolate
in
Sw
itzerland
in
2002
(G
enB
ank
accession
no.A
J459418);
b,orf1
is
also
annotated
as
yqkA
-yusZ
or
orfA
-orfB
(G
enB
ank
accession
no.A
Y
509004,E
U
219534,F
M
242710,F
M
244708,F
M
244709,F
M
244710,F
M
244712,and
F
M
244713);
c,insertions
of
IS10
or
IS26
w
ithin
IS440-sul3
w
ere
found
in
som
e
isolates
(G
enB
ank
accession
no.F
J587511,H
Q
875013,and
H
Q
875016)
(F
ig.1);
d,the
orf1-m
efB
sequence
w
as
absent
or
not
determ
ined;
e,the
presence
of
sequences
upstream
of
intI1
or
dow
nstream
of
tniC
w
as
not
determ
ined
or
w
as
absent;
f,
m
efB
is
absent
or
truncated.
aadA
2
corresponding
to
F
M
242710
is
a
hybrid
of
aadA
1a
and
aadA
2
containing
attC
a
a
d
A
1
a
. It
is
annotated
aadA
2
in
the
G
enB
ank
database.
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digested genomic DNA from E. coli transconjugants or wild-
type strains with appropriate probes (30). Characterization of
IncI1 plasmids also required RFLP profile comparison and
sequencing of the whole replication region, relaxase (nikB) (1,
30), and genes included in the plasmid MLST scheme (http:
//pubmlst.org/perl/bigsdb/bigsdb.pl?dbpubmlst_plasmid_seqdef).
Type IIIS3 was identified on blaSHV-12-IncI1 plasmids desig-
nated B, C1, C2, and D (100 to 150 kb). Genes linked to
replication (cop, repY, and repA), transfer (nikB, trbA-pndA,
sogS, and pilV), or restriction-modification systems (ardA) of
plasmids B and D were identical to those carried by
pCVM29188_101 from Salmonella enterica, an IncI1 plasmid
carrying sul3 and blaCMY-2 (GenBank accession no. CP001121).
Plasmid B was identified from 1997 to 2006 in ESBL strains
from different continents (data not shown). Plasmids C1 and
C2 were considered IncI1-mosaic plasmids, as repA carried by
plasmid C1 was similar to that carried by IncK plasmid R387,
and plasmid C2 harbors repA and sogS alleles that are different
from those harbored by pCVM29188_101. The repY and nikB
genes carried by plasmid E were identical to those carried by
IncI1 pSL476_91 and pRYC106 (GenBank accession no.
NC_011081 and GQ892053, respectively). The type IS3 inte-
gron was located on IncI1 plasmids similar to those of types B
and D, while the type IIS3 integron was linked to nontransfer-
able IncY, IncI1/I, or IncB/O plasmids.
In summary, this work describes the recent spread of the
IS440-sul3 platform, facilitated by its location on highly IncI1-
transferable plasmids and by IS26-promoted rearrangements
among multidrug resistance transposons and/or plasmids har-
bored by frequent E. coli clones. Coselection exerted by other
antibiotics and/or biocides to which sulfonamide-resistant
strains are also resistant, and the low fitness cost of plasmids in
which sul genes are located, might be responsible for the
spread and persistence of sul3, as suggested for other genes
encoding trimethoprim-sulfonamide resistance (9, 29). The
concurrent emergence and dissemination of the DHPS sul3
and ESBL genes among human Enterobacteriaceae since the
early 1990s suggest the recent recruitment of adaptive mech-
anisms in different environments (animals and humans ex-
posed to beta-lactams and sulfonamides) by the same predom-
inant genetic platforms.
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